Search Results 421-430 of 18841 for crohns disease

1. Pediatric MSC-AFP Sub-study for Crohn's Fistula - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

2. A Study of the Effectiveness and Safety of Mongersen (GED-0301) for the Treatment of Patients with Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to test the effectiveness and safety of an experimental medication GED-0301 (mongersen) in patients who have active Crohn's disease ...

3. Francis A. Farraye, M.D., M.S. - Mayo Clinic Faculty Profiles

   ... and Crohn's disease against COVID-19 , hepatitis B and shingles; Contraceptive options for women with Crohn's disease and menopause in women with IBD; Fecal ...

4. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

   A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... and stage of disease, and previous ...

5. A Study To Evaluate The Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderate To Severe Crohn's Disease (MK-7240-008) - Mayo Clinic

   ... and safety of tulisokibart in participants with moderately to severely active Crohn's disease. ... and stage of disease, and previous treatments or health ...

6. Digestive Diseases Clinical Trials - Medical Professionals

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

7. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   ... Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

8. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

   ... and older and for the treatment of Crohn's disease in children 6 years of age and older. However, safety and efficacy have not been established in children ...

9. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic ...

10. Christina Y. Ha, M.D. - Mayo Clinic Faculty Profiles

    Ha, M.D., specializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis. Her IBD clinical care ...